First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Background: COVID-19 is primarily known as a respiratory illness; however, many patients
present to hospital without respiratory symptoms. The association between non-respiratory …

Little is known on the burden of co-infections and superinfections in a specific setting such
as the respiratory COVID-19 sub-intensive care unit. This study aims to (i) assess the …

Contexto: A heparina tem sido estudada como uma possível opção terapêutica antiviral
para o tratamento de infecções por coronavírus. Neste estudo, investigamos o uso da …

Больные с терминальной стадией хронической болезни почек, получающие лечение
гемодиализом, имеют один из самых высоких показателей летальности при COVID-19 …

Background During the height of the COVID-19 pandemic in 2020, 11% of patients who
were hospitalized in France were immediately admitted to intensive care. We aimed to …

Objectives To our best knowledge, no study in France has comprehensively investigated the
prehospital history of patients admitted for severe cases of COVID-19.'Patients' voice is an …

El SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) ha provocado mas de
767 millones de infecciones y cerca de 7 millones de muertes y ha desestabilizado incluso …

The COVID-19 pandemic has driven the experimental, off-label treatments with co-
administration of supportive therapies for many patients with severe infections and …

Candida dubliniensis phenotypically mimics Candida albicans in its microbiological
features; thus, its clinical characteristics have yet to be fully elucidated. Here we report the …